Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P0
Near historical low
vs 2Y Ago
-2.9x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-55.31M-68.4%
2024$-32.84M-269.8%
2023$19.35M+196.2%
2022$-20.12M+23.4%
2021$-26.27M-